A
Amarin Corp PlcAMRN
Amarin is a global pharmaceutical company committed to reducing the cardiovascular disease (CVD) burden for patients and communities and to advancing the science of cardiovascular care around the world. We own and support a global branded product approved by multiple regulatory authorities based on a track record of proven efficacy and safety and backed by robust clinical trial evidence. Our commercialization model includes a direct sales approach in the.
US StocksHealthcareSmall CapBiotechnology
AMRN Price Trend
Amarin Corp Plc · Full TradingView Chart
NASDAQ:AMRN